Key result
Applying 2017 ACC/AHA criteria increases rural Chinese hypertension prevalence by ~22 percentage points.
Why the study?
To estimate the percentage of rural Chinese adults with hypertension and recommended antihypertensive treatment according to the 2017 ACC/AHA guideline compared with the 2010 Chinese guideline.
Does the application of the 2017 ACC/AHA hypertension guideline increase the estimated prevalence of hypertension and recommended treatment compared to the 2010 Chinese guideline in rural Chinese adults?
Cross-Sectional (n=11,747)
Yes
Does the application of the 2017 ACC/AHA hypertension guideline increase the estimated prevalence of hypertension and recommended treatment compared to the 2010 Chinese guideline in rural Chinese adults?
Applying the 2017 ACC/AHA hypertension guidelines to a rural Chinese population substantially increases the prevalence of hypertension and slightly increases the proportion recommended for pharmacological treatment compared to the 2010 Chinese guidelines.
Answers are grounded in this paper and cite their sources.
Alerts to higher hypertension burden under US thresholds in rural China; leaves open optimal guideline thresholds without outcome data.
OBJECTIVES: The present study estimated the percentage of rural Chinese adults with hypertension and recommended pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the 2010 Chinese Guideline for the Management of Hypertension. DESIGN: Cross-sectional study. SETTING: Three counties in rural areas of northeastern China. PARTICIPANTS: A total of 11 747 eligible individuals aged ≥35 years from rural areas of northeastern China were selected for the present analysis. MAIN OUTCOME MEASURES: The percentage of rural Chinese adults with hypertension and recommended pharmacological antihypertensive treatment according to the 2017 ACC/AHA guideline and the 2010 Chinese Guideline for the Management of Hypertension, and the proportion of rural Chinese adults taking antihypertensive medication with blood pressure (BP) above the 2017 ACC/AHA guideline and the 2010 Chinese guideline treatment goal. RESULTS: The mean age of the study population was 53.9±10.8 years and 53.7% of the participants were women. According to the 2017 ACC/AHA guideline and the 2010 Chinese guideline, the crude prevalence of hypertension was 72.2% and 49.8%, respectively, and the percentage of recommended antihypertensive medications for rural Chinese adults was 56.4% and 51.4%, respectively. Among these rural Chinese adults taking antihypertensive medications, 96.7% had above goal BP according to the 2017 ACC/AHA guideline compared with 86.1% with above goal BP according to the 2010 Chinese guideline. CONCLUSION: The present analysis demonstrated that compared with the 2010 Chinese guideline, the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage of rural Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended antihypertensive medications. More intensive management is suggested to improve the control rate of hypertension among rural Chinese adults.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2020) conducted a cross-sectional in Hypertension (n=11,747). 2017 ACC/AHA high blood pressure guideline vs. 2010 Chinese Guideline for the Management of Hypertension was evaluated on Prevalence of hypertension. Application of the 2017 ACC/AHA hypertension guideline to rural Chinese adults increased the defined prevalence of hypertension from 49.8% to 72.2% compared with the 2010 Chinese guideline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: